Haiming Chen

Prof. Dr. Haiming Chen


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Fitoterapia
Verified
Journal Article
Closed access
HCHaiming Chen
Haiming Chen
HLHuijun Liao
Huijun Liao
YLYuhong Liu
Yuhong Liu
YZYifeng Zheng
Yifeng Zheng
XWXiaoli Wu
Xiaoli Wu
ZSZi-ren Su
Zi-ren Su

1 January 2015 in Experimental Gerontology
Verified
Journal Article
Closed access
SKSong-Zhi Kong
Song-Zhi Kong
HCHaiming Chen
Haiming Chen
XYXiu-Ting Yu
Xiu-Ting Yu
XZXie Zhang
Xie Zhang
XFXue-Xuan Feng
Xue-Xuan Feng
ZSZi-ren Su
Zi-ren Su

1 June 2015 in International Immunopharmacology
Verified
Journal Article
Closed access
YLYu-Hong Liu
Yu-Hong Liu
ZZZhen-Biao Zhang
Zhen-Biao Zhang
YZYi-Feng Zheng
Yi-Feng Zheng
HCHaiming Chen
Haiming Chen
XYXiu-Ting Yu
Xiu-Ting Yu
ZSZi-ren Su
Zi-ren Su

1 January 2012 in International Immunopharmacology
Verified
Journal Article
Closed access
YLYu-Cui Li
Yu-Cui Li
SPShao-Zhong Peng
Shao-Zhong Peng
HCHaiming Chen
Haiming Chen
FZFeng-Xue Zhang
Feng-Xue Zhang
PXPei-Ping Xu
Pei-Ping Xu
ZSZi-ren Su
Zi-ren Su

1 December 2012 in Phytomedicine
Verified
Journal Article
Closed access
YLYu-Cui Li
Yu-Cui Li
HLHai-Chun Liang
Hai-Chun Liang
HCHaiming Chen
Haiming Chen
LTLi-Rong Tan
Li-Rong Tan
YYYu-Yang Yi
Yu-Yang Yi
XLXiao-Ping Lai
Xiao-Ping Lai

19 August 2015 in Experimental Biology and Medicine
Verified
Journal Article
Closed access
XCXiao-Ying Chen
Xiao-Ying Chen
HCHaiming Chen
Haiming Chen
YLYu-Hong Liu
Yu-Hong Liu
ZZZhen-Biao Zhang
Zhen-Biao Zhang
YZYi-Feng Zheng
Yi-Feng Zheng
XHXiaoqi Huang
Xiaoqi Huang
Pogostemonis Herba, known as “Guang-Huo-Xiang” in Chinese, has been widely used in the treatment of gastrointestinal dysfunction. Pogostone is one of the major constituents of Pogostemonis Herba. The aim was to scientifically evaluate the possible gastroprotective effect and the underlying mechanisms of pogostone against indomethacin-induced gastric ulcer in rats. Rats were orally treated with vehicle, lansoprazole (30 mg/kg) or pogostone (10, 20 and 40 mg/kg) and subsequently exposed to acute gastric lesions induced by indomethacin. Gross evaluation, histological observation, gastric mucosal superoxide dismutase activity, glutathione content, catalase activity, malonaldehyde level and prostaglandin E2 production were performed. Immunohistochemistry and reverse transcription polymerase chain reaction for cyclooxygenase-1 and cyclooxygenase-2, as well as terminal deoxynucleotidyltransferase-mediated dUTP nick-end labeling assay, immunohistochemistry for heat-shock protein 70, B-cell lymphoma-2 and Bax were conducted. Results indicated that rats pretreated with pogostone showed remarkable protection from the gastric mucosa damage compared to vehicle-treated rats based on the ulcer index and inhibition percentage. Histologically, oral administration of pogostone resulted in observable improvement of gastric injury, characterized by reduction of necrotic lesion, flattening of gastric mucosa and alleviation of submucosal edema with hemorrhage. Pogostone pretreatment significantly raised the depressed activities of superoxide dismutase, glutathione and catalase, while reduced the elevated malonaldehyde level compared with indomethacin-induced group. Pogostone-pretreated group induced a significant increase in gastric mucosal prostaglandin E2 level and obvious up-regulation of protein levels and mRNA expressions of cyclooxygenase-1 and cyclooxygenase-2. Furthermore, antiapoptotic effect of pogostone was verified by terminal deoxynucleotidyltransferase-mediated dUTP nick-end labeling assay, and the apoptotic process triggered by pogostone involved the up-expression of heat-shock protein70 and B-cell lymphoma-2 protein, and suppression of Bax protein expressions in the ulcerated tissues. It is speculated that the gastroprotective effect of pogostone against indomethacin-induced gastric ulceration might be associated with its stimulation of cyclooxygenase-mediated prostaglandin E2, antioxidant and antiapoptotic effect.